This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Patricia McLoughlin: Innovator in Cancer Treatment
Introduction
Patricia McLoughlin is a distinguished inventor based in Newcastle, GB. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on improving patient outcomes by identifying predictive biomarkers for treatment efficacy.
Latest Patents
Patricia holds a patent for a "Predictive marker for EGFR inhibitor treatment." This invention provides a biomarker that predicts the clinical benefit of EGFR inhibitor treatment in cancer patients. Her groundbreaking work aims to enhance personalized medicine approaches in oncology.
Career Highlights
Patricia is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her role involves extensive research and collaboration with other experts in the field. She has dedicated her career to advancing cancer treatment methodologies.
Collaborations
Throughout her career, Patricia has worked alongside notable colleagues such as Paul Delmar and Barbara Klughammer. These collaborations have fostered a productive environment for innovation and research in cancer therapies.
Conclusion
Patricia McLoughlin's contributions to cancer treatment through her patent and collaborative efforts highlight her commitment to improving patient care. Her work continues to inspire advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile